Publications
Publications 12676 - 12700 de 33557
| Titre | DOI |
|---|---|
|
Fluorescent indocyanine green angiography: Preliminary results in microsurgery monitoring V. Moris; S. Cristofari; A. Stivala; B. Lehre; C. Gengler; V. Rabuel; A. Srouji; N. Zwetyenga; D. Guilier 2019 |
10.1016/j.jormas.2019.07.006 |
|
Fluorescent organometallic gold(I) N-heterocyclic carbene complexes: synthesis and biological activities B. Bertrand; A. de Almeida; E.P.M. van der Burgt; A. Citta; A. Folda; E. Bodio; M. Picquet; M.Pia Rigobello; P. Le Gendre; A. Casini 2014 |
|
|
Fluorescent organometallic gold(I) N-heterocyclic carbene complexes: synthesis and biological activities B. Bertrand; A. de Almeida; E.P.M. van der Burgt; A. Citta; A. Folda; E. Bodio; M. Picquet; M.Pia Rigobello; P. Le Gendre; A. Casini 2014 |
|
|
Fluorescent Radiosensitizing Gold Nanoparticles G.Jimenez Sanchez; P. Maury; L. Stefancikova; O. Campion; G. Laurent; A. Chateau; F.Bouraleh Hoch; F. Boschetti; F. Denat; S. Pinel; J. Devy; E. Porcel; S. Lacombe; R. Bazzi; S. Roux 2019 |
10.3390/ijms20184618 |
|
Fluorination of Cu(001) Surface by C60F48 Molecule Adsorption M.N. Petukhov; A.I. Oreshkin; D.A. Muzychenko; S.I. Oreshkin 2020 |
10.1021/acs.jpcc.9b07408 |
|
Fluorogenic Enzyme-Triggered Domino Reactions Producing Quinoxalin-2(1H)-one-based Heterocycles G. Dejouy; K. Renault; Q. Bonnin; A. Chevalier; C. Michaudet; M. Picquet; I.E. Valverde; A. Romieu 2020 |
10.1021/acs.orglett.0c02287 |
|
Fluoroquinolone resistance in Achromobacter spp.: substitutions in QRDRs of GyrA, GyrB, ParC and ParE and implication of the RND efflux system AxyEF-OprN A. Magallon; M. Roussel; C. Neuwirth; J. Tetu; A.C. Cheiakh; B. Boulet; V. Varin; V. Urbain; J. Bador; L. Amoureux 2021 |
10.1093/jac/dkaa440 |
|
Fluoroquinolone Resistance Mechanisms and population structure of Enterobacter cloacae non-susceptible to Ertapenem in North-Eastern France T. Guillard; P. Cholley; A. Limelette; D. Hocquet; L. Matton; C. Guyeux; A.L. Lebreil; O. Bajolet; L. Brasme; J. Madoux; V. Vernet-Garnier; C. Barbe; X. Bertrand; C. de Champs; C.F.E. Grp 2015 |
10.3389/fmicb.2015.01186 |
|
Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study N. Isambert; A. Hervieu; C. Rebe; A. Hennequin; C. Borg; S. Zanetta; A. Chevriaux; C. Richard; V. Derangere; E. Limagne; J. Blanc; A. Bertaut; F. Ghiringhelli 2018 |
10.1080/2162402X.2018.1474319 |
|
Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patients F. Ghiringhelli; J. Vincent; F. Beltjens; L. Bengrine; S. Ladoire 2015 |
10.1007/s10637-015-0295-6 |
|
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study J.F. Bosset; G. Calais; L. Mineur; P. Maingon; S. Stojanovic-Rundic; R.J. Bensadoun; E. Bardet; A. Beny; J.C. Ollier; M. Bolla; D. Marchal; J.L. Van Laethem; V. Klein; J. Giralt; P. Clavere; C. Glanzmann; P. Cellier; L. Collette; E.O.R.T.C.Radiation Grp 2014 |
10.1016/S1470-2045(13)70599-0 |
|
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer C. Neuzillet; A. Casadei-Gardini; B. Brieau; C. Vivaldi; G. Brandi; D. Tougeron; R. Filippi; A. Vienot; N. Silvestris; A.L. Pointet; S. Lonardi; B. Rousseau; M. Scartozzi; L. Dahan; G. Aprile; S. Le Sourd; L. Evesque; A. Meurisse; A. Lievre; D. Vernerey; T. Boussaha; A. Heurgue; J. Desrame; T. Lecomte; W. Cacheux; J.B. Bachet; J.M. Phelip; V. Hautefeuille; F. Mary; C. Locher; A. Bidault-Thirot; L. Marthey; Y. Touchefeu; V. Moulin; A. Zaanan; J. Taieb; M. Casagrande; S. Murgioni; D. Santini; L. Fornaro; F. Montagnani; F. Leone; L. Faloppi; E. Giommoni; S.Eufemia Lutrino; A. Palloni; O. Brunetti; A. Argentiero; F. Bergamo; E. Vasile; E. Lai; P. Ziranu; V. Dadduzio; M. Rizzato; A. Pellino; M. Aglietta; A. Cappetta; S.Ken Garattini; D. Basile; N. Hammoudi; M. Puzzoni; A.G.E.O.Assoc Gast Onc; G.I.C.O.Italian Gr Cholangiocarcinom 2020 |
10.1002/ijc.33146, Early Access Date = {JUL 2020 |
|
Flux growth at 1230 degrees C of cubic Tb2O3 single crystals and characterization of their optical and magnetic properties P. Veber; M. Velazquez; G. Gadret; D. Rytz; M. Peltz; R. Decourt 2015 |
10.1039/c4ce02006e |
|
Fluxomics links cellular functional analyses to whole-plant phenotyping C. Salon; J.C. Avice; S. Colombie; M. Dieuaide-Noubhani; K. Gallardo; C. Jeudy; A. Ourry; M. Prudent; A.S. Voisin; D. Rolin 2017 |
10.1093/jxb/erx126 |
|
Flying Drosophila show sex-specific attraction to fly-labelled food L. Cazale-Debat; B. Houot; J.P. Farine; C. Everaerts; J.F. Ferveur 2019 |
10.1038/s41598-019-51351-1 |
|
Focal cryoablation: a treatment option for unilateral low-risk prostate cancer M. Durand; E. Barret; M. Galiano; F. Rozet; R. Sanchez-Salas; Y. Ahallal; P. Macek; J.M. Gaya; J. Cerruti; H. Devilliers; J. Loeffler; J. Amiel; G. Vallancien; X. Cathelineau 2014 |
10.1111/bju.12370 |
|
Focal Nodal SBRT or Elective Nodal Protracted Salvage Radiation Therapy for Prostate Cancer Patients With a Choline PET-CT Positive Nodal Relapse G. Crehange; P. Maingon; A. Cueff; G. Truc; K. Peignaux; F. Mazoyer; N. Vulquin; M. Quivrin; S. Naudy; E. Martin 2015 |
10.1016/j.ijrobp.2015.07.1159 |
|
Focal or whole gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for a post EBRT local failure: How best to spare the rectum? V. Guimas; M. Quivrin; A. Bertaut; E. Martin; F. Mazoyer; P. Maingon; L. Cormier; G. Crehange 2016 |
10.1200/jco.2016.34.2_suppl.e636 |
|
Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to spare the rectum? V. Guimas; M. Quivrin; A. Bertaut; E. Martin; D. Chambade; P. Maingon; F. Mazoyer; L. Cormier; G. Crehange 2016 |
10.1016/j.brachy.2016.03.014 |
|
Focus Issue on Unique Materials, Techniques, and Environments Y. Wouters; B.A. Pint; D. Monceau; M. Vilasi; S. Chevalier; L. Latu-Romain; C. Desgranges 2021 |
10.1007/s11085-021-10081-4 |
|
Focus on an unusual rise in pancreatic cancer incidence in France A.M. Bouvier; Z. Uhry; V. Jooste; A. Drouillard; L. Remontet; G. Launoy; N. Leone; F.Network Ca FRA 2017 |
10.1093/ije/dyx088 |
|
Focus on stereotactic radiotherapy: A new way to treat severe ventricular arrhythmias? F. Sacher; E. Gandjbakhch; P. Maury; C. Jenny; J. Khalifa; S. Boveda; P. Defaye; D. Gras; D. Klug; G. Laurent; N. Lellouche; J. Mansourati; E. Marijon; O. Piot; J. Taieb; H. Cochet; P. Maingon; E. Pruvot; L. Fauchier; F.Soc Cardiology 2021 |
10.1016/j.acvd.2020.11.003 |
|
Focus on the Odon Device (TM): Technical improvements, mechanical principles and progress of the clinical research program N. Mottet; A. Bourtembourg; A. Eckman-Lacroix; O. Forner; C. Mougey; J.P. Metz; R. Ramanah; D. Riethmuller 2020 |
10.1016/j.gofs.2020.03.011 |
|
Focused linearly-polarized-light scattering from a silver nanowire: Experimental characterization of the optical spin-Hall effect D. Paul; D.K. Sharma; G.V.Pavan Kumar 2021 |
10.1103/PhysRevA.103.013520 |
|
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma J.F. Guion-Dusserre; V. Lorgis; J. Vincent; L. Bengrine; F. Ghiringhelli 2015 |
10.3748/wjg.v21.i7.2096 |